Etoposide Hepatic Dose Adjustment

Adjust etoposide dose based on hepatic function: reduce by 50% for bilirubin 1.5–3 mg/dL or AST above 3x ULN; hold for bilirubin above 5 mg/dL or severe hepatic impairment.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Adjust etoposide dose based on hepatic function: reduce by 50% for bilirubin 1.5–3 mg/dL or AST above 3x ULN; hold for bilirubin above 5 mg/dL or severe hepatic impairment

Each component has a specific meaning:

  • Hepatic function: reduce by 50% — The hepatic function: reduce by 50% recorded for the scenario being assessed.

Note: Interpret the etoposide hepatic adjust result against the thresholds and context described above.

How to Use

Enter the hepatic function: reduce by 50% for the scenario you are assessing. Adjust etoposide dose based on hepatic function: reduce by 50% for bilirubin 1.5–3 mg/dL or AST above 3x ULN; hold for bilirubin above 5 mg/dL or severe hepatic impairment. Use the etoposide hepatic adjust result to inform your calculation.

Frequently Asked Questions